(Q38494723)

3 September 2017

1 reference

title

The link between depression and diabetes: the search for shared mechanisms (English)

1 reference

3 September 2017

Khalida Ismail

3

0 references

author name string

Calum D Moulton

series ordinal

1

1 reference

PubMed ID

25995124

3 September 2017

John C Pickup

series ordinal

2

1 reference

3 September 2017

17 May 2015

1 reference

The Lancet: Diabetes & Endocrinology

3 September 2017

1 reference

3 September 2017

3

1 reference

3 September 2017

6

1 reference

3 September 2017

461-471

1 reference

The prevalence of comorbid depression in adults with diabetes: a meta-analysis

3 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Age of onset of mental disorders: a review of recent literature

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

SCAN. Schedules for Clinical Assessment in Neuropsychiatry

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Comparison of depressive symptoms in type 2 diabetes using a two-stage survey design

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Constructs of depression and distress in diabetes: time for an appraisal

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

The relationship between changes in depression symptoms and changes in health risk behaviors in patients with diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Prevalence of depression in individuals with impaired glucose metabolism or undiagnosed diabetes: a systematic review and meta-analysis of the European Depression in Diabetes (EDID) Research Consortium

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Early development, stress and depression across the life course: pathways to depression in a national British birth cohort

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Association of childhood adversities and early-onset mental disorders with adult-onset chronic physical conditions

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Psychosocial stress at work doubles the risk of type 2 diabetes in middle-aged women: evidence from the Whitehall II study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Repeated job strain and the risk of depression: longitudinal analyses from the Whitehall II study.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Cardiac risk factors in patients with diabetes mellitus and major depression

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in patients with uncontrolled type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

The Pathways Study: a randomized trial of collaborative care in patients with diabetes and depression

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Cost-effectiveness of a multicondition collaborative care intervention: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Depression and poor glycemic control: a meta-analytic review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Diabetes distress but not clinical depression or depressive symptoms is associated with glycemic control in both cross-sectional and longitudinal analyses

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Depression is not associated with diabetes control in minority elderly

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Longitudinal analysis of depressive symptoms and glycemic control in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

High risk for cardiovascular disease in Chinese type 2 diabetic patients with major depression--a 7-year prospective analysis of the Hong Kong Diabetes Registry

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Association of depression with accelerated cognitive decline among patients with type 2 diabetes in the ACCORD-MIND trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Depression and type 2 diabetes over the lifespan: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

A test for common genetic and environmental vulnerability to depression and diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Analysis of the type 2 diabetes-associated single nucleotide polymorphisms in the genes IRS1, KCNJ11, and PPARG2 in type 1 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Pro12Ala polymorphism in PPARgamma2 associated with depression in Chinese nonagenarians/centenarians

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Depression in pregnancy, infant birth weight and DNA methylation of imprint regulatory elements

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Fetal origins of adult disease: strength of effects and biological basis.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Low birth weight, preterm birth and small for gestational age association with adult depression: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Is type II diabetes mellitus a disease of the innate immune system?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Inflammatory markers and risk of type 2 diabetes: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Interleukin-1-receptor antagonist in type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Salicylate (salsalate) in patients with type 2 diabetes: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

From inflammation to sickness and depression: when the immune system subjugates the brain

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Insights from interferon-α-related depression for the pathogenesis of depression associated with inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

A meta-analysis of cytokines in major depression

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Efficacy of adjunctive celecoxib treatment for patients with major depressive disorder: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

The association between depressive symptoms and systemic inflammation in people with type 2 diabetes: findings from the South London Diabetes Study.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Elevated levels of hs-CRP are associated with high prevalence of depression in japanese patients with type 2 diabetes: the Diabetes Distress and Care Registry at Tenri (DDCRT 6).

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Depressive symptoms and white blood cell count in coronary heart disease patients: prospective findings from the Heart and Soul Study.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart Association

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Association between raised inflammatory markers and cognitive decline in elderly people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Elevated specific peripheral cytokines found in major depressive disorder patients with childhood trauma exposure: a cytokine antibody array analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Association of lifecourse socioeconomic status with chronic inflammation and type 2 diabetes risk: the Whitehall II prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Stress hormones: physiological stress and regulation of metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

The role of stress and the hypothalamic-pituitary-adrenal axis in the pathogenesis of the metabolic syndrome: neuro-endocrine and target tissue-related causes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Do corticosteroids damage the brain?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Meta-analyses of structural regional cerebral effects in type 1 and type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Reduced expression of glucocorticoid-inducible genes GILZ and SGK-1: high IL-6 levels are associated with reduced hippocampal volumes in major depressive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Dex/CRH test cortisol response in outpatients with major depression and matched healthy controls

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Bio-social origins of depression in the community. Interactions between social adversity, cortisol and serotonin neurotransmission

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

The neurobiological consequences of early stress and childhood maltreatment

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Do depressed patients without activation of the hypothalamus-pituitary-adrenal (HPA) system have metabolic disturbances?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Mineralocorticoid receptor antagonist spironolactone prevents chronic corticosterone induced depression-like behavior

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Modulation of the mineralocorticoid receptor as add-on treatment in depression: a randomized, double-blind, placebo-controlled proof-of-concept study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Spironolactone for poorly controlled hypertension in type 2 diabetes: conflicting effects on blood pressure, endothelial function, glycaemic control and hormonal profiles

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

A systematic review and meta-analysis of the association between depression and insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Depressive symptoms, insulin resistance, and risk of diabetes in women at midlife

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Depressive symptom clusters as predictors of 6-year increases in insulin resistance: data from the Pittsburgh Healthy Heart Project

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

PPAR-γ agonism as a modulator of mood: proof-of-concept for pioglitazone in bipolar depression

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Does pioglitazone improve depression through insulin-sensitization? Results of a randomized double-blind metformin-controlled trial in patients with polycystic ovarian syndrome and comorbid depression.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Circadian rhythm disturbances in depression

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Interactions between sleep, circadian function, and glucose metabolism: implications for risk and severity of diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Sleep duration, insomnia, and markers of systemic inflammation: results from the Netherlands Study of Depression and Anxiety (NESDA)

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Self-reported sleep duration is associated with the metabolic syndrome in midlife adults

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Sleep architecture variation: a mediator of metabolic disturbance in individuals with major depressive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

The Munich vulnerability study on affective disorders: premorbid polysomnographic profile of affected high-risk probands.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Should we listen to our clock to prevent type 2 diabetes mellitus?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Regulation of core clock genes in human islets

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Circadian dysregulation of clock genes: clues to rapid treatments in major depressive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Antidepressant medication use, weight gain, and risk of type 2 diabetes: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Antidepressant medication use and risk of hyperglycemia and diabetes mellitus: a noncausal association?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Effects of antidepressants on glucose metabolism and diabetes mellitus type 2 in adults

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Sertraline for prevention of depression recurrence in diabetes mellitus: a randomized, double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Psychological interventions to improve glycaemic control in patients with type 1 diabetes: systematic review and meta-analysis of randomised controlled trials.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Changes in depressive symptoms and glycemic control in diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Type 1 diabetes mellitus and major depressive disorder: evidence for a biological link

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Metabolic and inflammatory links to depression in youth with diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

The effect of parental expressed emotion on glycaemic control in children with Type 1 diabetes. Parental expressed emotion and glycaemic control in children.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Parenting behavior, child functioning, and health behaviors in preadolescents with type 1 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Reducing stress and supporting positive relations in families of young children with type 1 diabetes: a randomized controlled study for evaluating the effects of the DELFIN parenting program

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Interpersonal predictors of HbA(1c) in patients with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Psychological adjustment and diabetic control

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Depressive symptoms predict change in glycemic control in adolescents with type 1 diabetes: rates, magnitude, and moderators of change.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Puberty decreases insulin sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Adolescent and parent diabetes distress in type 1 diabetes: the role of self-efficacy, perceived consequences, family responsibility and adolescent-parent discrepancies

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Coping skills training for youth with diabetes mellitus has long-lasting effects on metabolic control and quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Psycho-educational interventions for children and young people with Type 1 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

The interrelationships among paternal and maternal parenting stress, metabolic control, and depressive symptoms in adolescents with type 1 diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Characteristics of persons with an eating disorder and type 1 diabetes and psychological comparisons with persons with an eating disorder and no diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Depression, disturbed eating behavior, and metabolic control in teenage girls with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Improving depression screening for adolescents with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

High prevalence of depressive symptoms in well-controlled adolescents with type 1 diabetes treated with continuous subcutaneous insulin infusion

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Prevalence of depression among young people with Type 1 diabetes: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Relationships of diabetes-specific emotional distress, depression, anxiety, and overall well-being with HbA1c in adult persons with type 1 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

Depression in adults in the T1D Exchange Clinic Registry

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900134-5

7 January 2021

10.1016/S2213-8587(15)00134-5

Identifiers

DOI

1 reference

3 September 2017

1 reference

PubMed ID

25995124